Predicting Recurrence in HR+/HER2- Early Breast Cancer
Shengjing Hospital
Shengjing Hospital
Cancer Trials Ireland
Lyell Immunopharma, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
KK Women's and Children's Hospital
Severance Hospital
University of Wisconsin, Madison
Protean BioDiagnostics
Zhejiang Cancer Hospital
First Hospital of China Medical University
Queen Mary University of London
ChineseAMS
Amwise Diagnostics Pte. Ltd.
Vanderbilt-Ingram Cancer Center
Longhua Hospital
Xijing Hospital
Mayo Clinic
Vanderbilt-Ingram Cancer Center
Uppsala University
Assaf-Harofeh Medical Center